BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Share PriceBiofil Chemicals & Pharmaceuticals

₹41.4
-0.4 (-0.96%)
As on 31 March, 2023 | 22:02 BSE: 524396 NSE: BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Biofil Chemicals & Pharmaceuticals

Start SIP

Biofil Chemicals & Pharmaceuticals Share Price

  • Over 1 Month -7.49%
  • Over 3 Month -25%
  • Over 6 Month -13.39%
  • Over 1 Year -28.19%

Biofil Chemicals & Pharmaceuticals Key Statistics

P/E Ratio 208.4
PEG Ratio 57.6
Market Cap Cr 67
Price to Book Ratio 4
EPS 0.4
Dividend 0
Relative Strength Index 40.83
Money Flow Index 51.32
MACD Signal -1.56
Average True Range 2.91

Biofil Chemicals & Pharmaceuticals Investment Rating

  • Master Rating:
  • Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 18.07 Cr. on a trailing 12-month basis. An annual revenue de-growth of -38% needs improvement, Pre-tax margin of 5% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Biofil Chemicals & Pharmaceuticals Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 13122
Operating Expenses Qtr Cr 12122
Operating Profit Qtr Cr 0000
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr 0000

Biofil Chemicals & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹41.4
-0.4 (-0.96%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 43.13
  • 50 Day
  • 46.01
  • 100 Day
  • 48.68
  • 200 Day
  • 52.01
  • 20 Day
  • 43.06
  • 50 Day
  • 46.65
  • 100 Day
  • 50.6
  • 200 Day
  • 51.1

Biofil Chemicals & Pharmaceuticals Resistance and Support

PIVOT
₹42.2
Resistance
First Resistance 42.9
Second Resistance 44
Third Resistance 44.7
RSI 40.83
MFI 51.32
MACD Single Line -1.56
MACD -1.42
Support
First Resistance 41.1
Second Resistance 40.4
Third Resistance 39.3

Biofil Chemicals & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 32,336 2,013,886 62.28
Week 34,675 1,974,034 56.93
1 Month 28,005 1,681,432 60.04
6 Month 82,165 3,420,532 41.63

Biofil Chemicals & Pharmaceuticals Result Highlights

Biofil Chemicals & Pharmaceuticals Synopsis

NSE-Medical-Ethical Drugs

Biofil Chemicals belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 22.38 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2022. Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709.
Market Cap 67
Sales 18
Shares in Float 0.86
No of funds 6
Yield
Book Value 3.99
U/D Vol ratio 0.5
LTDebt / Equity
Alpha -0.03
Beta 0.76

Biofil Chemicals & Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 46.82%46.82%46.82%
Foreign Portfolio Investors
Financial Institutions/ Banks 0.04%0.04%0.08%
Individual Investors 38.04%37.87%37.84%
Others 15.1%15.27%15.26%

Biofil Chemicals & Pharmaceuticals Management

Name Designation
Mr. Ramesh Shah Managing Director
Mr. Ketan Shah Whole Time Director
Mr. Romil Shah Non Executive Director
Mrs. Shaila Jain Independent Director
Mr. Satish Beohar Independent Director
Mr. Ashok Kumar Ramawat Independent Director

Biofil Chemicals & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Biofil Chemicals & Pharmaceuticals FAQs

What is Share Price of Biofil Chemicals & Pharmaceuticals ?

Biofil Chemicals & Pharmaceuticals share price is ₹41 As on 31 March, 2023 | 21:48

What is the Market Cap of Biofil Chemicals & Pharmaceuticals ?

The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹67.4 Cr As on 31 March, 2023 | 21:48

What is the P/E ratio of Biofil Chemicals & Pharmaceuticals ?

The P/E ratio of Biofil Chemicals & Pharmaceuticals is 208.4 As on 31 March, 2023 | 21:48

What is the PB ratio of Biofil Chemicals & Pharmaceuticals ?

The PB ratio of Biofil Chemicals & Pharmaceuticals is 4 As on 31 March, 2023 | 21:48

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number